Navigation Links
Celladon Corporation Announces Presentation of First-in-Human Gene Transfer to Treat Heart Failure at the 12th Annual Meeting of the American Society of Gene Therapy
Date:5/26/2009

ctly to heart cells with minimally invasive cardiac catheterization is currently underway. This clinical study represents the first-in-human trial of enzyme replacement therapy in heart failure using AAV and has demonstrated acceptable safety and produced quantitative evidence of biological activity across a number of parameters important for assessing heart failure. Celladon is testing the hypotheses that restoring SERCA2a enzyme production will improve ventricular function in patients with advanced heart failure.

About Celladon

Celladon Corporation, based in La Jolla, California, was launched in October 2004 as a privately held biotechnology company founded with the goal of becoming the leader in developing molecular therapies for the treatment of heart failure. The company's products target the key enzyme deficiency in advanced heart failure, SERCA2a, which regulates calcium cycling and contractility in heart muscle cells. Celladon's first product candidate, MYDICAR, delivers the gene for the SERCA2a enzyme. MYDICAR is currently being tested in Phase 1 and 2 clinical trials. Celladon is also developing traditional small molecule activators of SERCA2a for the treatment of heart failure. To learn more about Celladon, visit Celladon's website at www.celladon.net.


'/>"/>
SOURCE Celladon Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Celladon Announces Presentation of Clinical Data From First-in-Human MYDICAR(R) Trial for Advanced Heart Failure at American Heart Association Scientific Sessions
2. Juvenile Diabetes Research Foundation to Honor Duane DeSisto of Insulet Corporation and Senator Edward M. Kennedy at 27th Annual Hearts & Heroes Gala
3. CEL-SCI Corporation Releases Letter to Shareholders
4. Optigenex Inc. Signs New License and Distribution Agreement With Itochu Corporation of Japan
5. DOR BioPharma, Inc. Executes $400,000 Equity Investment Agreement With Numoda Corporation
6. Alba Therapeutics Corporation Announces the Next Clinical Trial of Its Lead Compound, Larazotide Acetate and Promotions
7. AndroScience Corporation Announces Phase 2a Study Results on ASC-J9(TM) for the Treatment of Acne
8. The Quigley Corporation Licenses Naturally Derived Compound For Scar Improvement; License Requires Payments Totaling $1.1 Million To The Quigley Corporation Over A Five Year Period For Exclusive Ownership
9. CEL-SCI Corporation Releases Letter to Shareholders
10. Chemstar Corporation Offers Comprehensive Deep Cleaning Programs to Combat Salmonella, Listeria, and E. coli in Retail Supermarkets
11. Christie Cookie Recalls Certain Lots of Peanut Butter Cookie Dough Due to Expanded Recall by Peanut Corporation of America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... DIEGO , Aug. 26, 2014  Sorrento ... a late-stage clinical oncology company developing new treatments ... that it has received funding to advance an ... potential treatment of IPF, which affects more than ... the lungs increases and patients gradually lose the ...
(Date:8/26/2014)... , Aug. 26, 2014 MNX ... that it has renewed a multi-year contract providing ... the third largest spinal device company in the ... medical device industry is well suited to MNX,s ... that every shipment involves a surgeon, surgical team ...
(Date:8/26/2014)... DIEGO , Aug. 26, 2014 Profil ... research organization (CRO) focused on diabetes and obesity, announced ... completion of more than 200 phase I – IIa ... the treatment of type 1 and type 2 diabetes. ... of research is what it represents for the public ...
Breaking Medicine Technology:Sorrento Awarded NIH Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF) 2Sorrento Awarded NIH Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF) 3MNX Global Logistics renews multi-year contract with NuVasive, Inc. 2Profil Institute Reaches Milestone in Early Phase Clinical Research for Diabetes 2Profil Institute Reaches Milestone in Early Phase Clinical Research for Diabetes 3
... Improvement With Every-Four-Week Subcutaneous SIMPONI Despite Previous Medication ... June 9 A new analysis demonstrated that ... severely active rheumatoid arthritis (RA) who had prior ... received subcutaneous injections of SIMPONI(TM) (golimumab) once every ...
... in June Issue of Circulation , , SILVER ... Corporation (Nasdaq: UTHR ) and Eli Lilly ... the results of a pivotal 16-week study showing that ... improved exercise capacity and improved time to clinical worsening ...
Cached Medicine Technology:New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 2New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 3New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 4New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 5New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 6New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 7New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 8New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 9New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 10Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily 2Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily 3Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily 4Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily 5Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily 6
(Date:8/27/2014)... August 27, 2014 Casey Diekman, assistant ... Technology (NJIT), is helping to gain greater insight into ... life. , Evolution has harmonized the behavior of humans ... that include the cycle of light and dark experienced ... clock controls hormone production related to natural patterns of ...
(Date:8/27/2014)... California (PRWEB) August 27, 2014 In My ... “Journey Candle Collection” to provide a growing number of women ... scent-based tool for goal setting and relaxing at the same ... soy candles, uses scent memory and visualization to help women ... their life each time they light a candle and enjoy ...
(Date:8/27/2014)... 2014 PartnerTech Inc ., ... major systems integration and electronics manufacturer, announces a ... the first U.S. designed and manufactured whole body ... combination of manufacturing expertise, location, flexibility, and speed-to-market ... headquartered in Atlanta, GA, offers a whole body ...
(Date:8/26/2014)... 2014 Hearing aids are not ... for plan holders to determine what their hearing care benefits ... several additional health plans and has published benefit details on ... . , The following is a list of insurances ... provider: , NYSHIP/ NYS Empire Plan - Hearing Aid Benefit ...
(Date:8/26/2014)... Leelanau Peninsula, MI (PRWEB) August 27, 2014 ... Stompede event is a fabulous time to visit the ... providing a magnificent backdrop to wine tasting fun in ... 7, 2014. , Kicking off the festivities is an ... Saturday at Ciccone Vineyards in Suttons Bay. A unique ...
Breaking Medicine News(10 mins):Health News:NJIT Researcher Receives New NSF Funding to Study Fundamental Rhythms of Life 2Health News:NJIT Researcher Receives New NSF Funding to Study Fundamental Rhythms of Life 3Health News:NJIT Researcher Receives New NSF Funding to Study Fundamental Rhythms of Life 4Health News:In My Solitude Unveils Eco Candle Line That May Improve Performance 2Health News:PartnerTech Inc. and Impact Cryotherapy Announce Made in America Manufacturing Initiative 2Health News:PartnerTech Inc. and Impact Cryotherapy Announce Made in America Manufacturing Initiative 3Health News:East End Hearing of Long Island Now Participating in Many Local Health Plans 2Health News:East End Hearing of Long Island Now Participating in Many Local Health Plans 3Health News:Leelanau Peninsula’s Annual Harvest Stompede Offers One-of-a-Kind Walk or Run Through the Vineyards for Walkers, Runners and Wine Tasting Spectators Alike 2Health News:Leelanau Peninsula’s Annual Harvest Stompede Offers One-of-a-Kind Walk or Run Through the Vineyards for Walkers, Runners and Wine Tasting Spectators Alike 3
... the latest issue of the journal Antimicrobial Agents and ... occur in the human saliva can lead to new ... in children., ,Researchers at the University of Washington ... between dental caries (tooth decay) prevalence in children and ...
... been known to be associated with health hazards ... But it is known not until recently that ... exposure to mineraloil., ,The exact causative factor ... genetic, hormonal factors and environmental fcators have been ...
... doubled to 1 million worldwide and tripled in Africa and Asia. ... AIDS. Though, there is a immense increase in antiretroviral // treatment, ... goal to treat 3 million people by 2005, will never happen ... of those in Africa and 14% of those in Asia have ...
... control cream and a potent neurotoxin, used by Hollywood ... derived form a bacteria, Clostridium botulinum, that causes food ... this form of neurotoxin is playing an important role ... is exploring basic nerve cell function, minute changes that ...
... general health of people. , ,With health consciousness ... for improving health // status has considerably increased. The ... would be dependent to a large scale on the ... plants that the body uses to make vitamin A. ...
... teeth, called dentigerous cysts, may be harmless to the tooth ... head and neck area., ,Dentigerous cysts are painless, considered ... tooth eruption. However, head and neck specialists have recently encountered ... neck infections or as a deep neck space abscess. , ...
Cached Medicine News:Health News:B-Carotene Increases Oral Cancer Risk In Smokers 2Health News:Dental Cysts Can Cause Infections In Head And Neck 2
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Medicine Products: